Plexera is a dedicated provider of high-throughput Surface Plasmon Resonance Imaging (SPRi) technology, delivering one-stop compound library screening solutions tailored for life science research and novel drug development.
Our core product portfolio encompasses the PlexArray HT system, a full range of customized chips, and complementary SPRi detection equipment—all backed by end-to-end professional technical support. Leveraging our proprietary surface chemistry technology, we achieve high-density immobilization of small-molecule compounds on glass slide substrates, pioneering a new paradigm for high-efficiency, high-precision biomolecular interaction detection.
Trusted by leading research institutions and pharmaceutical enterprises worldwide, our solutions power breakthroughs across academic research, preclinical drug discovery, and clinical diagnostics. Plexera is committed to transcending traditional technological limitations, driving greater accuracy and efficiency in scientific innovation. We operate out of our ISO 13485:2016 certified facility in Edinburgh, Scotland—upholding rigorous quality standards for every product and service we deliver.